drugset / Trial / NCT02435797

Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction

NCT02435797

Phase 4 Unknown 100 enrolled Xuzhou Central Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

To evaluate whether nicorandil as an adjunctive therapy for acute myocardial infarction (AMI) reduces reperfusion injury.

Timeline

Start
2015-04
Primary completion
2015-08
Completion
2016-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicorandil Other / unclassified 2 mg Other